A new analysis by the International Agency for Research on Cancer and collaborators evaluates the latest and future global burden of female breast cancer in about 50 countries worldwide.
Reduced screening rates and a higher prevalence of triple-negative breast cancer are driving elevated rates of advanced breast cancer in a geographic hotspot in Wilmington, Delaware, according to findings by researchers at ChristianaCare’s Cawley Center for Translational Cancer Research at the Helen F. Graham Cancer Center & Research Institute.
